These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354 [TBL] [Abstract][Full Text] [Related]
23. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Brenner H; Tao S Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981 [TBL] [Abstract][Full Text] [Related]
24. Screening for colorectal cancer: current status in Japan. Saito H Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S78-84. PubMed ID: 11052482 [TBL] [Abstract][Full Text] [Related]
25. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests. Levin B; Hess K; Johnson C Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267 [TBL] [Abstract][Full Text] [Related]
26. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760 [TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Castiglione G; Sala P; Ciatto S; Grazzini G; Mazzotta A; Rossetti C; Spinelli P; Bertario L Eur J Cancer Prev; 1994 Sep; 3(5):399-405. PubMed ID: 8000308 [TBL] [Abstract][Full Text] [Related]
28. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942 [TBL] [Abstract][Full Text] [Related]
29. Screening for colon cancer: A test for occult blood. Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687 [TBL] [Abstract][Full Text] [Related]
30. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527 [TBL] [Abstract][Full Text] [Related]
31. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Castiglione G; Grazzini G; Ciatto S Br J Cancer; 1992 Jun; 65(6):942-4. PubMed ID: 1616868 [TBL] [Abstract][Full Text] [Related]
32. Rehydration of guaiac-based faecal occult blood tests in mass screening for colorectal cancer. An economic perspective. Walker AR; Whynes DK; Hardcastle JD Scand J Gastroenterol; 1991 Feb; 26(2):215-8. PubMed ID: 2011707 [TBL] [Abstract][Full Text] [Related]
33. Replacing guaiac-based tests with immunochemical tests in colorectal cancer screening. Schlackman N Am J Med; 2003 Aug; 115(2):154; author reply 154-5. PubMed ID: 12893403 [No Abstract] [Full Text] [Related]
34. A comparison of fecal occult-blood tests for colorectal-cancer screening. Allison JE; Tekawa IS; Ransom LJ; Adrain AL N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970 [TBL] [Abstract][Full Text] [Related]
35. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150 [TBL] [Abstract][Full Text] [Related]
36. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test]. Launoy G Pathol Biol (Paris); 2009 Sep; 57(6):488-92. PubMed ID: 18834677 [TBL] [Abstract][Full Text] [Related]
37. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Vart G; Banzi R; Minozzi S Prev Med; 2012 Aug; 55(2):87-92. PubMed ID: 22634386 [TBL] [Abstract][Full Text] [Related]
38. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
39. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476 [TBL] [Abstract][Full Text] [Related]